Short-term side effects of COVID-19 vaccines: A cross-sectional study in Jordan.
COVID-19
Jordan
immunization
pandemics
side effects
vaccine
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
30 11 2022
30 11 2022
Historique:
pubmed:
28
6
2022
medline:
2
11
2022
entrez:
27
6
2022
Statut:
ppublish
Résumé
The rapid manufacturing of vaccines has increased hesitancy toward receiving the COVID-19 vaccines. Clarifying what to expect after vaccination and revealing the possible side effects will lower hesitancy toward receiving the COVID-19 vaccine and increase public awareness. This descriptive cross-sectional survey-based study was conducted in Jordan (August 2021) to collect data on the short-term side effects following the COVID-19 vaccines. An extensive literature review was conducted by the research team to assist in developing the first draft of the survey. The survey was tested for face and content validity and piloted test to improve readability and clarity. The survey was organized into two sections (demographics and perceived COVID-19 vaccines' side effects). Data were analyzed using the Statistical Package for Social Science (SPSS). A total of 1,044 participants were enrolled in the study. The most received vaccine among the participants was Pfizer-BioNTech (51.1%). The most frequently reported side effects were sore arm at the injection site (84.65%), fatigue (84.48%), discomfort (65.43%), muscles/joint pain (61.38%), drowsiness (58.73%), and headache (58.38%). More side effects were significantly associated with being older (p = 0.046), having an allergy (p = 0.024) or rheumatoid arthritis (p = 0.023), and participants who take NSAIDs regularly (p = 0.029). Short-term side effects of COVID-19 vaccines seem to be mostly local or transient in nature. Older age and certain comorbidities may increase susceptibility to side effects.
Identifiants
pubmed: 35759219
doi: 10.1080/21645515.2022.2082792
pmc: PMC9621041
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2082792Références
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102207
pubmed: 34280733
Vaccines (Basel). 2021 Jun 01;9(6):
pubmed: 34205917
Indian J Psychol Med. 2013 Apr;35(2):121-6
pubmed: 24049221
Hum Vaccin Immunother. 2022 Dec 31;18(1):2039017
pubmed: 35240939
PLoS One. 2022 Feb 24;17(2):e0264371
pubmed: 35202444
Radiology. 2003 May;227(2):309-13
pubmed: 12732691
Vaccines (Basel). 2021 Oct 09;9(10):
pubmed: 34696264
Vaccines (Basel). 2021 May 26;9(6):
pubmed: 34073382
Vaccines (Basel). 2022 Mar 03;10(3):
pubmed: 35335020
Int J Infect Dis. 2021 Oct;111:219-226
pubmed: 34384899
J Clin Med. 2021 Apr 01;10(7):
pubmed: 33916020
Biology (Basel). 2021 Aug 05;10(8):
pubmed: 34439984
Vaccines (Basel). 2021 Jun 03;9(6):
pubmed: 34204971
Vaccines (Basel). 2021 May 18;9(5):
pubmed: 34070196
Int J Gen Med. 2021 Apr 19;14:1389-1401
pubmed: 33907443
Hum Vaccin Immunother. 2022 Dec 31;18(1):1981086
pubmed: 34614383
Am Fam Physician. 2002 Dec 1;66(11):2113-20
pubmed: 12484693
Respir Med. 2021 Oct;187:106569
pubmed: 34399368